Search

everythinglearnresearchcommunity

for

Search:↓

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Fat tissue cells are a promising option for healing various diseases, but more research is needed to ensure they are safe and effective.

The document concludes that accurate diagnosis of hair disorders is crucial and requires a range of diagnostic methods.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

PRP treatment may increase hair density and reduce hair loss, but more research is needed.

Sunlight worsens hair loss; protect scalp.

Surgical methods like suction blister grafting and split-thickness skin grafting are highly successful for vitiligo repigmentation, but choosing the right patients is crucial for success.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

PRP treatment helps hair growth in most cases, but more research needed.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Finasteride and minoxidil mix works better for hair growth than minoxidil alone, with similar safety.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.